“…Alginate derivatives are an attractive biomaterial for numerous applications, including tissue engineering, cell encapsulation, and wound healing [ 172 , 173 , 174 , 175 ], in situ formation of gels, controlled drug delivery and release systems, as well as targeted drug delivery [ 176 , 177 , 178 , 179 ]. The pool of pharmaceutical products based on alginates includes: - Drugs administered orally (Gastrotuss baby syrup [ 180 ], Algicid suspension/tablets [ 181 ], Gaviscon Double Action Liquid [ 182 ] and Tablets [ 183 ]), creating a mechanical barrier between the stomach and esophagus that prevents reflux, choking, dysphagia, heartburn, belching, and irritability, which accelerates the movement of the stomach and regenerates the mucous membranes of the esophagus
- Materials applied to the skin (Flaminal Forte gel [ 184 ], Purilon Gel gel [ 185 ], Saf-Gel gel [ 186 ], Hyalogran dressing [ 187 ], SeaSorb dressing [ 188 ], Tromboguard dressing [ 189 , 190 ], Fibracol Plus dressing [ 191 ], Algivon dressing [ 192 ], Guardix-SG [ 193 , 194 ]), which affect dissolution of the dry layer and necrotic tissue, ensure a moist environment at the wound surface, have hemostatic and antibacterial activity, and influence tissue granulation, epithelialization, and healing
- Rectal agents (Natalsid suppositories [ 195 ]) used for chronic hemorrhoids, proctitis, and chronic anal fissures after rectal surgery
- Periodontal agents (Progenix putty, Progenix plus injection [ 196 ]), used for bone defects, and Emdogain gel [ 197 , 198 ] used for intraosseous defects and defects of mandibular furcation with minimal atrophy of the interdental bone
- Agents applied arthroscopically (ChondroArt 3D injection [ 199 ]), used in degenerative diseases of the joints and spine.
…”